VitaNova Life Sciences Corporation (YJGJD) Net Income by Year
VitaNova Life Sciences Corporation reported $851K in net income in fiscal year 2025. This represents an increase of 503.9% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $745K in net income. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters VitaNova Life Sciences Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
YJGJD Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $745K | $851K+503.9% | $141Kn/m | -$24K-117.3% | $140Kn/m | -$52Kn/m | -$72Kn/m | -$106Kn/m | -$2Kn/m | -$7K |
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
YJGJD Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More VitaNova Life Sciences Corporation financials
Frequently Asked Questions
VitaNova Life Sciences Corporation reported $851K in net income in fiscal year 2025.
VitaNova Life Sciences Corporation (YJGJD) net income rose by 503.9% year over year, from $141K to $851K in fiscal year 2025.
VitaNova Life Sciences Corporation (YJGJD) reported $745K in net income over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Across the 9 fiscal years this page covers, VitaNova Life Sciences Corporation (YJGJD) net income went from -$7K in fiscal year 2017 to $851K in fiscal year 2025.
VitaNova Life Sciences Corporation (YJGJD) reported -$44K in net income in Q3 2026. This represents a decrease of 160.8% from the same quarter a year earlier.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what VitaNova Life Sciences Corporation (YJGJD) reported on that line in every period on record.